BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 243 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $41 | +28.1% | 6,713 | +5.8% | 0.00% | – |
| Q1 2024 | $32 | -77.9% | 6,347 | -73.8% | 0.00% | -100.0% |
| Q4 2023 | $145 | -21.6% | 24,257 | -7.2% | 0.00% | -50.0% |
| Q3 2023 | $185 | +0.5% | 26,146 | 0.0% | 0.00% | +100.0% |
| Q2 2023 | $184 | -8.9% | 26,146 | +8.0% | 0.00% | -50.0% |
| Q1 2023 | $202 | -36.9% | 24,220 | -13.2% | 0.00% | -33.3% |
| Q4 2022 | $320 | -99.9% | 27,901 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $352,000 | +20.5% | 27,901 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $292,000 | -22.1% | 27,573 | +19.4% | 0.00% | 0.0% |
| Q1 2022 | $375,000 | -43.7% | 23,092 | -52.0% | 0.00% | +50.0% |
| Q4 2021 | $666,000 | +91.9% | 48,138 | +99.2% | 0.00% | -33.3% |
| Q3 2021 | $347,000 | -15.2% | 24,162 | -6.5% | 0.00% | 0.0% |
| Q2 2021 | $409,000 | +74.8% | 25,849 | +12.2% | 0.00% | -66.7% |
| Q1 2021 | $234,000 | +28.6% | 23,040 | -5.6% | 0.01% | +28.6% |
| Q4 2020 | $182,000 | +119.3% | 24,414 | +0.6% | 0.01% | +75.0% |
| Q3 2020 | $83,000 | -21.0% | 24,276 | +10.1% | 0.00% | -20.0% |
| Q2 2020 | $105,000 | +123.4% | 22,048 | -6.3% | 0.01% | +400.0% |
| Q1 2020 | $47,000 | -31.9% | 23,538 | +17.4% | 0.00% | 0.0% |
| Q4 2019 | $69,000 | +23.2% | 20,041 | +3.4% | 0.00% | 0.0% |
| Q3 2019 | $56,000 | -24.3% | 19,377 | -0.7% | 0.00% | -50.0% |
| Q2 2019 | $74,000 | -42.2% | 19,517 | +23.8% | 0.00% | -33.3% |
| Q1 2019 | $128,000 | +4.9% | 15,768 | +3.9% | 0.00% | 0.0% |
| Q4 2018 | $122,000 | +43.5% | 15,172 | +2.3% | 0.00% | +50.0% |
| Q2 2018 | $85,000 | +34.9% | 14,835 | +12.5% | 0.00% | 0.0% |
| Q1 2018 | $63,000 | -4.5% | 13,189 | -1.3% | 0.00% | 0.0% |
| Q4 2017 | $66,000 | +24.5% | 13,360 | +31.1% | 0.00% | 0.0% |
| Q3 2017 | $53,000 | – | 10,189 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |